Personalkatalog

Ai-Hong Li

Kontaktinformation
Befattning:	Forskare
Verksam vid:	Medicinsk biovetenskap
Avdelning:	Klinisk kemi
Adress:	Umeå universitet SE-901 85 Umeå Sverige
Besöksadress:	By 6M, bv och vån 2, Sjukhusområdet
Tel:	+46 90 785 25 07
Fax:	+46 90 785 44 84
E-postadress:	aihong.li@medbio.umu.se E-post 1 aihong.li@vll.se E-post 2
Webbsida:	http://www.medbio.umu.se/om-institutionen/personal/li-aihong/ Webbsida

Författare	Titel	År	Fulltext
Li, Xingru Wang, Sihan Sitaram, Raviprakash Tumkur; et al.	Single Nucleotide Polymorphisms in the Wilms' Tumour Gene 1 in Clear Cell Renal Cell Carcinoma PLoS ONE, 8(3): e58396-	2013	Hämta
Li, Aihong Brattsand, Göran	Stability of serum samples and hemolysis interference on the high sensitivity troponin T assay: Letter to the editor Clinical Chemistry and Laboratory Medicine, 49(2): 335-336	2011	-
Thörn, Ingrid Forestier, Erik Thuresson, Britt; et al.	Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006 European Journal of Haematology, 84(2): 117-127	2010	-
Sitaram, Raviprakash T Degerman, Sofie Ljungberg, Börje; et al.	Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways British Journal of Cancer, 103(8): 1255-1262	2010	-
Trageser, Daniel Iacobucci, Ilaria Nahar, Rahul; et al.	Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function Journal of Experimental Medicine, 206(8): 1739-1753	2009	-
Lönnerholm, Gudmar Thörn, Ingrid Sundström, Christer; et al.	In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia Leukemia research, 33(1): 46-53	2009	-

Sidansvarig: Åsa Lundsten
2010-11-02